Abstracts and Articles

Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis.

Kuo Yuan-Hung (YH);Teng Wei (W);Lin Po-Ting (PT);Chen Yen-Hao (YH);Su Chung-Wei (CW);Shen Eric Yi-Liang (EY);Huang Bing-Shen (BS);Wu Tsung-Han (TH);Cheng Jen-Yu (JY);Hsieh Yi-Chung (YC);Chen Wei-Ting (WT);Hung Chao-Hung (CH);Lin Shi-Ming (SM);Lin Chen-Chun (CC);Wang Jing-Houng (JH);Lin Chun-Yen (CY)

Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.

Sasaki Ryu (R);Shimose Shigeo (S);Saeki Issei (I);Ito Takanori (T);Takeuchi Yasuto (Y);Tani Joji (J);Tomonari Tetsu (T);Sasaki Kyo (K);Kakizaki Satoru (S);Hatanaka Takeshi (T);Miuma Satoshi (S);Shirono Tomotake (T);Iwamoto Hideki (H);Tanabe Norikazu (N);Yamamoto Takafumi (T);Kanayama Yuki (Y);Naganuma Atsushi (A);Nishina Sohji (S);Takayama Tetsuji (T);Kobara Hideki (H);Otsuka Motoyuki (M);Kawashima Hiroki (H);Takami Taro (T);Kawaguchi Takumi (T);Miyaaki Hisamitsu (H); ()

Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis.

Xiang Heng (H);She Zhihua (Z);Wang Liting (L);Peng Ye (Y);Zhang Lei (L);Tan Chongqing (C)

TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study.

Lin Po-Ting (PT);Teng Wei (W);Chen Wei-Ting (WT);Su Chung-Wei (CW);Hsieh Yi-Chung (YC);Lin Chen-Chun (CC);Lin Chun-Yen (CY);Lin Shi-Ming (SM)

Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study.

Jeong Oeuk (O);Chu Changhee (C);Kim Jungyeon (J);Lee Jae Seung (JS);Park Jun Yong (JY);Lee Kyung Eun (KE);Seong Jaehyun (J);Go Min Jin (MJ)

Functional Shunt with Small-for-Size Graft in Auxiliary Liver Transplantation for Portal Hypertension.

Qu Wei (W);Liu Ying (Y);Cai Ru-Zhou (RZ);Zhu Zhi-Jun (ZJ);Sun Li-Ying (LY);Wei Lin (L);Zeng Zhi-Gui (ZG)

Project Donor: A National Intervention to Improve the Health of Potential Living Donors.

Abbasi Ali B (AB);Shuman Daniela (D);Carmichael Kathryn (K);Sukumar Claire (C);Rorty Ruby (R);Zambeli-Ljepovic Alan (A);Stock Peter G (PG);Orandi Babak J (BJ)

Use of Machine Perfusion in Pediatric Liver Transplantation.

Ziogas Ioannis A (IA);Giorgakis Emmanouil (E);Yoeli Dor (D);Baimas-George Maria (M);Conover Katie R (KR);Feldman Amy G (AG);Kirchner Varvara A (VA);Barbas Andrew S (AS);Adams Megan A (MA);Taylor Sarah A (SA)

Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma.

Luo Jiefeng (J);Li Zhengxiong (Z);Gui Chengxia (C);Du Qiong (Q);Liu Jiyong (J)

The impact of single-nucleotide variants of hepatitis B virus and antiviral on liver cancer in gray zone patients.

Teng Wei (W);Chang Ting-Tsung (TT);Su Chien-Wei (CW);Xu Jun-Hao (JH);Hsu Chiu-Chi (CC);Chang Yu-Cheng (YC);Liu Wen-Chun (WC);Chiou Yu-Wei (YW);Chang Yu-Chuan (YC);Liang Yuh-Jin (YJ);Wu Jaw-Ching (JC)

Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab-Durvalumab.

Kuwano Akifumi (A);Tanaka Kosuke (K);Hamamoto Taikan (T);Kurosaka Kazuki (K);Suzuki Hideo (H);Yada Masayoshi (M);Ohishi Yoshihiro (Y);Sasaki Tomonari (T);Motomura Kenta (K)

Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria.

Dixon Wesley (W);Chandna Shaun (S);Sack Jordan S (JS);Gray Meagan (M);Brown Christina N (CN);Poreddy Sampath (S);Ha Kai (K);Schoech Michael R (MR);Zucker Stephen D (SD)

From Gene to Enzyme: Multidimensional Decoding of the GGT Molecular Family and Its Clinical Tumor Diagnosis.

Wang Fei (F);Yang Jianshan (J);Zhu Feng (F);Xu Xuebing (X);Zhao Junpeng (J);Xie Xudong (X);He Xuyang (X);Huang Yuxuan (Y);Zhou Lirong (L);Hu Xiaogang (X);Lu Xiaomin (X);Xiao Mingbing (M)

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study.

Qin Shukui (S);Gu Shanzhi (S);Chan Stephen L (SL);Bai Yuxian (Y);Ren Zhenggang (Z);Lin Xiaoyan (X);Chen Zhendong (Z);Jia Weidong (W);Jin Yongdong (Y);Guo Yabing (Y);Hu Xiaohua (X);Meng Zhiqiang (Z);Liang Jun (J);Xiong Jianping (J);Ren Hong (H);Yang Fang (F);Li Wei (W);Chen Yajin (Y);Zeng Yong (Y);Xu Li (L);Yuan Xianglin (X);Li Da (D);Sultanbaev Alexander (A);Pazgan-Simon Monika (M);Pisetska Margaryta (M);Melisi Davide (D);Ponomarenko Dmitriy (D);Du Jinghua (J);Shi Wei (W);Cheng Ann-Lii (AL);Kaseb Ahmed (A);Vogel Arndt (A); ()

Long-Term Outcomes of Patients Who Receive a Liver Transplant for Hepatitis B With Limited Use of Hepatitis B Immunoglobulin.

Roldan Giovanni A (GA);Loon Erica (E);Lake John (J);Lim Nicholas (N)

Free Testosterone Is Associated With Worse Survival in Patients With Advanced Chronic Liver Disease Awaiting Liver Transplantation.

Sogbe Miguel (M);Bromfield Brittany (B);Tellez Roberto (R);Bloomer Pamela M (PM);Bennett Nelson (N);Hughes Christopher B (CB);Dunn Michael A (MA);Ruiz-Margáin Astrid (A);Duarte-Rojo Andres (A)

Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for Transplant.

Feeney Kimberly M (KM);van Leeuwen Leonie (L);Todd Rachel (R);Fortier Avery K (AK);Rosowicz Andrew (A);Arvelakis Antonios (A);DiNorcia Joseph (J);Facciuto Marcelo (M);Holzner Matthew (M);Moon Jang (J);Rocha Chiara (C);Tabrizian Parissa (P);Schiano Thomas (T);Akhtar M Zeeshan (MZ);Kim-Schluger Leona (L);Florman Sander S (SS)

Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update.

Lampertico Pietro (P);Anolli Maria Paola (MP);Steppich Katja (K);Wedemeyer Heiner (H)